Hematology/Oncology

Top Story

Oxybutynin shows promise for managing hot flashes among breast cancer survivors

December 7, 2018
Meeting News

Addition of pembrolizumab to chemotherapy demonstrates promise in triple-negative breast cancer

December 7, 2018
SAN ANTONIO — The addition of pembrolizumab to neoadjuvant chemotherapy demonstrated promising antitumor activity and exhibited a manageable toxicity profile in a…
Meeting NewsPerspective

Lifestyle intervention improves outcomes for some breast cancer survivors

December 7, 2018
SAN ANTONIO — Completion of a lifestyle intervention program that focused on healthy habits appeared associated with weight loss and increased DFS among a cohort…
Meeting NewsPerspective

Exercise during adjuvant breast cancer treatment may improve cardiovascular function

December 7, 2018
SAN ANTONIO — A supervised 12-month exercise program improved cardiovascular function among women undergoing adjuvant breast cancer treatment, according to results…
Meeting News

Surgery choice affects quality of life among younger patients with breast cancer

December 7, 2018
SAN ANTONIO — Local therapy decisions appeared to significantly affect quality of life among young breast cancer survivors, according to study results presented at…
More Headlines »
CME

Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Video
Meeting News

VIDEO: Integrity chief among characteristics for succession in physician leadership

August 16, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »
Current Issues
View the Current Issue
HemOnc Today